Recent Patents on Inflammation & Allergy Drug Discovery
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 1
Author(s): Madhav Bhatia
Affiliation:
Export Options
About this article
Cite this article as:
Bhatia Madhav , Meet Our Editorial Board Member, Recent Patents on Inflammation & Allergy Drug Discovery 2018; 12 (1) . https://dx.doi.org/10.2174/1872213X1201180821094417
DOI https://dx.doi.org/10.2174/1872213X1201180821094417 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
27
1
Related Articles
-
Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Immunosuppression in Liver Transplantation: State of the Art and Future Perspectives
Current Pharmaceutical Design Paraneoplastic Neurological Syndromes - Diagnosis and Management
Current Pharmaceutical Design Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage
Current Neurovascular Research Current Issues and Regulations in Tendon Regeneration and Musculoskeletal Repair with Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Allergic and Pseudoallergic Reactions Induced by Glucocorticoids: A Review
Current Pharmaceutical Design Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
Current Neuropharmacology Innovative Topical Formulations for Treatment of Dermatitis
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy Impact of Epigenetic Alterations in the Development of Oral Diseases
Current Medicinal Chemistry Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding
Current Cancer Drug Targets State-of-the-Art Methodologies for the Discovery and Characterization of DNA G-Quadruplex Binders
Current Pharmaceutical Design Application of a Deep Matrix Factorization Model on Integrated Gene Expression Data
Current Bioinformatics Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies The Immune Response in SAPHO Syndrome: Deficiency, Hyper- Responsiveness, or Both?
Current Rheumatology Reviews Patent Selections
Recent Patents on Food, Nutrition & Agriculture Ras-Induced Senescence and its Physiological Relevance in Cancer
Current Cancer Drug Targets